| 期 |
栏目 |
标题 |
文件 |
| 卷 81, 编号 10 (2009) |
Editorial |
Current approaches to controlling type 2 diabetes |
|
| 卷 82, 编号 3 (2010) |
Editorial |
Impact of insulin therapy on insulin resistance and a risk for coronary heart disease and cardiovascular death in patients with type 2 diabetes |
|
| 卷 82, 编号 8 (2010) |
Editorial |
Impact of sibutramine (meridia) on body composition, peptide YY3-36 and serotonin levels in patients with exogenous constitutional obesity |
|
| 卷 82, 编号 8 (2010) |
Editorial |
Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus |
|
| 卷 82, 编号 12 (2010) |
Editorial |
Long-term effect of 3-week intravenous б-lipoic acid administration in symptomatic diabetic polyneutropathy with clinical manifestations |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity |
|
| 卷 83, 编号 10 (2011) |
Editorial |
Taurin in combined treatment of metabolic syndrome and diabetes mellitus |
|
| 卷 83, 编号 9 (2011) |
Editorial |
Acute coronary syndrome in patients with type 2 diabetes mellitus |
|
| 卷 92, 编号 9 (2020) |
Consensuns |
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2 |
(Rus)
|
| 卷 92, 编号 10 (2020) |
Original articles |
The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus |
(Rus)
|
| 卷 93, 编号 12 (2021) |
Original articles |
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial |
(Rus)
|
| 卷 94, 编号 10 (2022) |
Clinical notes |
Management of a patient with diabetes mellitus after total pancreatectomy. Case report |
(Rus)
|
| 卷 96, 编号 2 (2024) |
Clinical notes |
Total duodenopancreatectomy: the role of a multidisciplinary team approach in successful treatment. Case report |
(Rus)
|
| 卷 96, 编号 4 (2024) |
Reviews |
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review |
(Rus)
|
